Rock/nf-κb axis-dependent augmentation of angiotensinogen by angiotensin ii in primary-cultured preglomerular vascular smooth muscle cells

American Journal of Physiology - Renal Physiology

Volumn 306, Issue 6, 2014, Pages

  Miyata, Kayoko ^a   Satou, Ryousuke ^a   Shao, Weijian ^a   Prieto, Minolfa C ^a   Urushihara, Maki ^a   Kobori, Hiroyuki ^a   Navar, L Gabriel ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Afferent arteriole; Angiotensin II type 1 receptors; H 1152; Juxtamedullary nephron preparation; Parathenolide; Renin; Renin angiotensin system

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; ANGIOTENSINOGEN; APELIN RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; RHO KINASE; PARTHENOLIDE; RENIN; SESQUITERPENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTERIOLE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNOREACTIVITY; KIDNEY CELL; MALE; NONHUMAN; PREGLOMERULAR VASCULAR SMOOTH MUSCLE CELL; PRIMARY CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION; VASCULAR SMOOTH MUSCLE; AFFERENT ARTERIOLE; ANGIOTENSIN II TYPE 1 RECEPTORS; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; H-1152; JUXTAMEDULLARY NEPHRON PREPARATION; PARATHENOLIDE; PHYSIOLOGY;

AFFERENT ARTERIOLE; ANGIOTENSIN II TYPE 1 RECEPTORS; H-1152; JUXTAMEDULLARY NEPHRON PREPARATION; PARATHENOLIDE; RENIN; RENIN-ANGIOTENSIN SYSTEM;

ANGIOTENSIN II; ANGIOTENSINOGEN; ANIMALS; CELLS, CULTURED; MALE; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; RATS; RHO-ASSOCIATED KINASES; SESQUITERPENES;

EID: 84900300415     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00464.2013     Document Type: Article

References (53)

1. Acres OW, Satou R, Navar LG, Kobori H. Contribution of a nuclear factor-kappaB binding site to human angiotensinogen promoter activity in renal proximal tubular cells. Hypertension 57: 608-613, 2011.
2. Arendshorst WJ, Brannstrm K, Ruan X. Actions of angiotensin II on the renal microvasculature. J Am Soc Nephrol 10: 149-161, 1999.
3. Brands MW, Banes-Berceli AK, Inscho EW, Al-Azawi H, Allen AJ, Labazi H. Role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation. Hypertension 56: 1-6, 2010.
4. Casellas D, Bouriquet N, Artuso A, Walcott B, Moore LC. New method for imaging innervation of the renal preglomerular vasculature. Alterations in hypertensive rats. Microcirculation 7: 429-437, 2000.
5. 2+]i responses to ANG II. Am J Physiol Renal Physiol 288: F658-F664, 2005.
6. Cheng D, Zhu X, Gillespie DG, Jackson EK. Role of RACK1 in the differential proliferative effects of neuropeptide Y(1-36) and peptide YY(1-36) in SHR vs. WKY preglomerular vascular smooth muscle cells. Am J Physiol Renal Physiol 304: F770-F780, 2013.
7. Chun-Yu W, Kuo-Chin H, Yin-Hsiang C, Pe-Fang H, Kuei-Hui L, Wan-Wan L. The role of Rho-associated kinase in differential regulation by statins of interleukin-1β- and lipopolysaccharide-medoated nuclear factor kappa B activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells. Mol Pharmacol 69: 960-967, 2005.
8. Dubey RK, Roy A, Overbeck HW. Culture of renal arteriolar smooth muscle cells. Mitogenic responses to angiotensin II. Circ Res 71: 1143-1152, 1992.
9. Feng MG, Navar LG. Afferent arteriolar vasodilator effect of adenosine predominantly involves adenosine A2B receptor activation. Am J Physiol Renal Physiol 299: F310-F315, 2010.
10. Feng MG, Prieto M, Navar LG. Nebivolol-induced vasodilation of renal afferent arterioles involves 3-adrenergic receptor and nitric oxide synthase activation. Am J Physiol Renal Physiol 303: F775-F782, 2012.
11. Gonzalez AA, Lara LS, Luffman C, Seth DM, Prieto MC. Soluble form of the (pro)renin receptor is augmented in the collecting duct and urine of chronic angiotensin II-dependent hypertensive rats. Hypertension 57: 859-864, 2011.
12. Gonzalez AA, Luffman C, Bourgeois CR, Vio CP, Prieto MC. Angiotensin II-independent upregulation of cyclooxygenase-2 by activation of the (Pro)renin receptor in rat renal inner medullary cells. Hypertension 61: 443-449, 2013.
13. Guilluy C, Bregeon J, Toumaniantz G, Rolli-Derkinderen M, Retailleau K, Loufrani L, Henrion D, Scalbert E, Bril A, Torres RM, Offermanns S, Pacaud P, Loirand G. The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nat Med 16: 183-190, 2010.
14. Haller H, Lindscau C, Quass P, Luft FC. Intracellular actions of angiotensin II in vascular smooth muscle cells. J Am Soc Nephrol 10: s75-83, 1999.
15. 1A receptor null mice. Am J Physiol Renal Physiol 284: F538-F545, 2003.
16. 1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) 112: 417-428, 2007.
17. Ichihara A, Imig J, Inscho EW, Navar LG. Interactive nitric oxideangiotensin II influences on renal microcirculation in angiotensin IIinduced hypertension. Hypertension 31: 1255-1260, 1998.
18. Imig JD. Afferent arteriolar reactivity to angiotensin II is enhanced during the early phase of angiotensin II hypertension. Am J Hypertens 13: 810-818, 2000.
19. 1 receptor activation. J Hypertens 22: 811-818, 2004.
20. Inscho EW, Cook A, Webb RC, Jin LM. Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter. Am J Physiol Renal Physiol 296: F590-F597, 2009.
21. Kagami S, Urushihara M, Kitamura A, Kondo S, Hisayama T, Kitamura M, Löster K, Reutter W, Kuroda Y. PDGF-BB enhances alpha1beta1 integrin-mediated activation of the ERK/AP-1 pathway involved in collagen matrix remodeling by rat mesangial cells. J Cell Physiol 198: 470-478, 2004.
22. Kamiyama M, Garner M, Farragut KM, Kobori H. The establishment of a primary culture system of proximal tubule segments using specific markers from normal mouse kidneys. Int J Mol Sci 13: 5098-5111, 2012.
23. Kataoka C, Egashira K, Inoue S, Takemoto M, Ni W, Koyanagi M, Kitamoto S, Usui M, Kaibuchi K, Shimokawa H, Takeshita A. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats. Hypertension 39: 245-250, 2002.
24. Kobori H, Harrison-Bernard L, Navar LG. Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension. Hypertension 37: 1329-1335, 2001.
25. Kobori H, Ozawa Y, Acres OW, Miyata K, Satou R. Rho-kinase/ nuclear factor-κ_/angiotensinogen axis in angiotensin II-induced renal injury. Hypertens Res 34: 976-979, 2011.
26. Kobori H, Ozawa Y, Suzaki Y, Nishiyama A. Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol 16: 2073-2080, 2005.
27. 1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin IIdependent hypertension. Hypertension 43: 1126-1132, 2004.
28. Kyaw M, Yoshizumi M, Tsuchiya K, Kagami S, Izawa Y, Fujita Y, Ali N, Kanematsu Y, Toida K, Ishimura K, Tamaki T. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migra- tion of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation. Mol Pharmacol 65: 832-841, 2004.
29. Liu L, Gonzales A, McCormack M, Seth DM, Kobori H, Navar LG, Prieto MC. Increased renin excretion is associated with augmented urinary angiotensin II levels in chronic angiotensin II-infused hypertensive rats. Am J Physiol Renal Physiol 301: F1195-F1201, 2011.
30. Loirand G, Guerin P, Pacaud P. Rho kinases in cardiovascular physiology and pathophysiology. Circ Res 17: 322-334, 2006.
31. Mendes AC, Ferreira A, Pinheiro SV, Santos RA. Chronic infusion of angiotensin-(1-7) reduces heart angiotensin II levels in rats. Regul Pept 15: 29-34, 2005.
32. Muller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A, Theuer J, Breu V, Ganten D, Haller H, Luft FC. NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 35: 193-201, 2000.
33. Nakamura A, Hayashi K, Ozawa Y, Fujiwara K, Okubo K, Kanda T, Wakino S, Saruta T. Vessel- and vasoconstrictor-dependent role of rho/rho-kinase in renal microvascular tone. J Vasc Res 40: 244-251, 2003.
34. Navar LG, Arendshorst W, Pallone TL, Inscho EW, Imig JD, Bell PD. The renal microcirculation. In: Handbook of Physiology. Microcirculation, edited by Tuma RF, Duran WN, and Ley K. San Diego, CA: Elsevier, 2008, p. 550-683.
35. 1 receptor blockade. Am J Hypertens 13: 45S-54S, 2000.
36. Navar LG, Harrison-Bernard L, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 33: 316-322, 2002.
37. Ohashi N, Urushihara M, Satou R, Kobori H. Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygen species-ERK/JNK pathways. Hypertens Res 293: 1174-1181, 2010.
38. Ozawa Y, Kobori H. Crucial role of Rho-nuclear factor-_B axis in angiotensin II-induced renal injury. Am J Physiol Renal Physiol 292: F100-F109, 2007.
39. Ozawa Y, Kobori H, Suzaki Y, Navar LG. Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions. Am J Physiol Renal Physiol 292: F330-F339, 2007.
40. 1 and AT2 in vascular smooth muscle cells: molecular mechanisms. Circ Res 23: 1266-1272, 2000.
41. Rupérez M, Sanchez-Lorez E, Blanco-Colio LM, Esteban V, Rodríguez-Vita J, Plaza JJ, Egido J, Ruiz-Ortega M. The Rho-kinase pathway regulates angiotensin II-induced renal damage. Kidney Int Suppl 99: S39-S45, 2005.
42. Salomonsson M, Sorensen C, Arendshorst WJ, Steendahl J, Holstein- Rathlou NH. Calcium handling in afferent arterioles. Acta Physiol Scand 181: 421-429, 2004.
43. Satou R, Miyata K, Katsurada A, Navar LG, Kobori H. Tumor necrosis factor-_ suppresses angiotensinogen expression through formation of a p50/p50 homodimer in human renal proximal tubular cells. Am J Physiol Cell Physiol 299: C750-C759, 2010.
44. Shao W, Seth D, Navar LG. Angiotensin II type 1 receptor-mediated augmentation of urinary excretion of endogenous angiotensin II in Val5- angiotensin II-infused rats. Hypertension 56: 378-383, 2010.
45. Singh R, Singh A, Alavi N, Leehey DJ. Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose. J Am Soc Nephrol 14: 873-880, 2003.
46. Skov K, Mulvamy M. Structure of renal afferent arterioles in the pathogenesis of hypertension. Acta Physiol Scand 181: 397-405, 2004.
47. Takamatsu M, Urushihara M, Kondo S, Shimizu M, Morioka T, Oite T, Kobori H, Kagami S. Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy. Pediatr Nephrol 23: 1257-1267, 2008.
48. Urushihara M, Kobori H. Angiotensinogen expression is enhanced in the progression of glomerular disease. Int J Clin Med 1: 378-387, 2011.
49. Urushihara M, Ohashi N, Miyata K, Satou R, Acres OW, Kobori H. Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis. Hypertension 57: 586-593, 2011.
50. van Nieuw Amerongen GP, van Hinsbergh V. Cytoskeletal effects of rho-like small guanine nucleotide-binding proteins in the vascular system. Arterioscler Thromb Vasc Biol 21: 300-311, 2001.
51. Wang C, Chin SY, Navar LG. Impairment of pressure-natriuresis and renal autoregulation in ANG II-induced hypertensive rats. Am J Renal Physiol 279: F319-F325, 2000.
52. Yamakawa T, Tanaka S, Numaguchi K, Yamakawa Y, Motley ED, Ichihara S, Inagami T. Involvement of Rho-kinase in angiotensin IIinduced hypertrophy of rat vascular smooth muscle cells. Hypertension 35: 313-318, 2000.
53. Yoo TH, Li JJ, Kim JJ, Jung DS, Kwak SJ, Ryu DR, Choi HY, Kim JS, Kim HJ, Han SH, Lee JE, Han DS, Kang SW. Activation of the renin-angiotensin system within podocytes in diabetes. Kidney Int 71: 1019-1027, 2007.